Secondary Logo

Journal Logo

January 23, 2004 - Volume 18 - Issue 2
pp: N1-N2,137-363


Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)

Katlama, Christine; Dominguez, Stéphanie; Gourlain, Karine; More

AIDS. 18(2):217-226, January 23, 2004.

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Violin, Michela; Cozzi-Lepri, Alessandro; Velleca, Rossella; More

AIDS. 18(2):227-235, January 23, 2004.

Virological phenotype switches under salvage therapy with lopinavir–ritonavir in heavily pretreated HIV-1 vertically infected children

Galán, Isabel; Jiménez, José L; González-Rivera, Milagros; More

AIDS. 18(2):247-255, January 23, 2004.

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

Wallis, Robert S; Kyambadde, Peter; Johnson, John L; More

AIDS. 18(2):257-264, January 23, 2004.


Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe

Zijenah, Lynn S; Moulton, Lawrence H; Iliff, Peter; More

AIDS. 18(2):273-280, January 23, 2004.

Thirteen years HIV-1 sentinel surveillance and indicators for behavioural change suggest impact of programme activities in south-west Tanzania

Jordan-Harder, Brigitte; Maboko, Leonard; Mmbando, Donan; More

AIDS. 18(2):287-294, January 23, 2004.

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

van Griensven, Frits; Keawkungwal, Jaranit; Tappero, Jordan W; More

AIDS. 18(2):295-301, January 23, 2004.

Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand

Vanichseni, Suphak; Tappero, Jordan W; Pitisuttithum, Punnee; More

AIDS. 18(2):311-316, January 23, 2004.